Clinically, AGC1 expression was markedly decreased in colon and rectal cancer tissues compared to normal tissues in the GEPIA2 online database (Fig. 3E), and patients with lower AGC1 expression exhibited significantly shorter overall survival time (Fig. 3F). This evidence concerns the gene SLC25A12 and rectal cancer.